CD47 and neoplasm: Cheng et al. produced CD47-overexpressed hybrid nanovesicles by fusing gene-engineered exosomes with drug-loaded thermosensitive liposomes, which integrated photothermal therapy (PTT) with immunotherapy for the anti-tumor treatment by blocking CD47 [141].